Liver Cancer Treatment in India
Liver cancer treatment in India depends on the stage of the tumour and how well the liver is working. Early-stage cancer can often be cured with surgery, ablation or liver transplant. Intermediate disease is usually treated with TACE or TARE, and advanced disease with immunotherapy and targeted drugs. At Livcure, Dr. Ankur Garg's team reviews your scans and reports, recommends a plan, and can start treatment within days of your first consultation.
Book a Consultation
Connect with our specialists for personalized guidance.
Introduction
Liver cancer is the sixth most common cancer worldwide and one of the leading causes of cancer death. In 2022, about 866,000 people were diagnosed, and about 759,000 died. India recorded about 38,700 new cases and about 37,000 deaths that year. When a family gets this diagnosis, the first question is always the same: "What can we do?"
The answer depends on the type of liver cancer, the stage, and how well the liver is still working. Liver cancer treatment in India has advanced considerably, and patients today have access to surgical and non-surgical options that match international standards. Getting the right evaluation from the right team early makes all the difference.
With over 25 years of experience and more than 4,500 liver transplants and hepatobiliary procedures, the Livcure team evaluates each patient and builds a treatment plan based on evidence rather than assumptions.
Find Your Nearest Centre For Liver Cancer Treatment
Each centre offers liver cancer care programme, led by the same core team, so you can choose based on location and convenience.
Liver Cancer Treatment Options in India
Surgical Options
Liver Resection (Hepatectomy): Dr. Ankur Garg’s team at LivCure performs liver resection surgery using both open and minimally invasive approaches, tailored to the extent of resection needed.
Liver Transplant: Liver transplant removes both the tumour and the diseased liver. LivCure’s liver transplant programme at Paras Health has one of the highest-volume teams in North India.
Locoregional Options
Ablation Therapy: Radiofrequency Ablation (RFA) uses heat from radio waves. Microwave Ablation (MWA) works similarly but is faster for larger tumours. Cryoablation uses extreme cold to freeze tumour tissue. LivCure offers ablation therapy as part of its HCC treatment pathway.
TACE (Transarterial Chemoembolization): The standard treatment for intermediate-stage HCC (BCLC-B). TACE delivers chemotherapy directly into the tumour’s blood supply while blocking that supply, targeting the tumour from the inside while cutting off its nutrition.
TARE (Transarterial Radioembolization): Similar to TACE but uses tiny radioactive microspheres (Y-90) instead of chemotherapy. TARE is gaining traction in India as an option for patients who aren’t ideal candidates for TACE.
Radiation (SBRT): Stereotactic body radiotherapy delivers precise, high-dose radiation to the tumour. Its exact role is still being defined, but it may be used in selected patients when surgery or ablation isn't suitable.
Liver Cancer Treatment by Stage
Doctors use the BCLC staging system to match treatment to tumour size, liver function and general fitness. The final plan is always individual.
|
BCLC stage |
What it means |
Usual first options |
|
0 (very early) |
Single tumour up to 2 cm, good liver function |
Ablation; resection if ablation isn't possible |
|
A (early) |
Single tumour, or up to 3 small nodules, good fitness |
Resection, ablation or liver transplant |
|
B (intermediate) |
Multiple tumours, no spread into vessels |
Transplant in selected patients, TACE or TARE, or systemic therapy |
|
C (advanced) |
Spread into blood vessels or outside the liver |
Systemic therapy (immunotherapy or targeted drugs) |
|
D (terminal) |
Severe liver failure or poor general condition |
Supportive care; transplant for selected patients who meet criteria |
Liver Cancer Survival Rate
Survival depends mainly on the stage at diagnosis. In US registry data (SEER, 2014–2020), 5-year relative survival was 37% for localized liver cancer, 13% for regional and 3% for distant, and 22% for all stages combined. For early-stage liver cancer treated with transplant, 5-year survival is in the range of 60% to 70% (American Cancer Society).
These figures describe groups of patients treated years ago, not any one person. Newer treatments mean people diagnosed today may do better. Livcure's own outcomes are listed below.
Liver Cancer Treatment Cost in India
Cost depends on the treatment, the length of hospital stay, and whether a transplant is needed. Approximate ranges at Livcure's centres:
|
Treatment type |
Approximate cost in India |
|
Radiofrequency or microwave ablation (RFA/MWA) |
₹1,00,000–₹3,00,000 per session |
|
Transarterial chemoembolization (TACE) |
₹1,00,000–₹4,50,000 per session |
|
Transarterial radioembolization (TARE/Y-90) |
₹4,00,000–₹15,00,000 per treatment |
|
Liver resection surgery |
₹3,00,000–₹8,00,000 |
|
Living donor liver transplant |
₹18,00,000–₹25,00,000 |
|
Chemotherapy |
₹50,000–₹2,00,000 per cycle |
|
Targeted therapy |
₹1,50,000–₹5,00,000 per month |
|
Immunotherapy |
Approximately ₹40,000–₹5,00,000+ per cycle |
Final Thoughts
Cost: Liver cancer surgery in India costs 80-90% less than equivalent procedures in the USA. A liver transplant in the USA can exceed $500,000. At a top-tier centre in India, the same procedure costs between $25,000 and $40,000. Even after accounting for travel and accommodation, international patients typically save over 60% in total treatment costs.
Technology: India’s leading liver centres use the same equipment as hospitals in the USA and Europe: robotic surgical systems, TACE and TARE suites, advanced MRI, and access to current immunotherapy protocols. The Indian liver cancer therapeutics market was valued at $54 million in 2024 and is projected to reach $90.55 million by 2030, at a CAGR of 9.17%, reflecting increased investment in the field.
Surgical volume: High volume matters in liver cancer treatment centres . Surgeons who perform more hepatectomies and transplants have measurably better outcomes in the literature. Dr. Ankur Garg has performed over 4,500 liver transplants and HPB procedures over 25 years of clinical practice.
Access: There are no multi-year waiting lists. Patients can get an expert evaluation, a treatment plan, and start care within days of arriving at LivCure’s centres at Paras Health.
Frequently Asked Questions
Is liver cancer curable ? expand_more
Whether liver cancer can be cured depends mainly on the stage at diagnosis and how well the liver is functioning. Early-stage liver cancer, especially hepatocellular carcinoma (HCC), can often be treated with curative intent using liver resection or liver transplant. In selected patients, transplant offers long-term survival with 5-year survival rates of 60–70%.
What are the treatment options for liver cancer? expand_more
Liver cancer treatment includes surgical options like liver resection and liver transplant, and locoregional options like ablation therapy, TACE and TARE. The right option depends on tumour stage, liver function, and overall health of the patient.
Who is at risk of developing liver cancer? expand_more
The main risk factors for liver cancer are chronic hepatitis B or C infection, liver cirrhosis, heavy alcohol use, and non-alcoholic fatty liver disease. In India, hepatitis B is the most common cause, raising HCC risk by up to 100-fold.
Where can I get liver cancer treatment in India? expand_more
LivCure provides liver cancer treatment across three Paras Health centres in India, located in Gurugram, Panchkula and Patna.
How can I book a consultation with Dr. Ankur Garg? expand_more
You Can Fill the consultation form or contact directly at +91 87002 71068 to book at your nearest centre.